AVALON™ Grand Plus is a non-surgical filler which contains highly-purified hyaluronic acid (24 mg/ml) and lidocaine (0.3%) for anaesthetic effects.

It is designed to be injected into the deep dermis for the correction of moderate to severe facial wrinkles and folds , cheeks, chin augmentation and shaping of the contours of the face and jawline.

The viscous filler, AVALON™ Grand Plus is an ideal solution for the correction of thick skin and deep wrinkles and it is also efficient in restoring volume with results lasting from 12 – 18 months*.

*The duration of effect might vary depending on the individual physical characteristics of the patient, injection method and type of the procedure. 

Cross-linked Hyaluronic Acid in AVALON™ Fillers

MCO™ Tech. (Minimising Cross-linking-agent by Optimising reaction Technology) is a technology developed by Koru Pharmaceuticals’ R&D Institute.

The cross-linking agent serves to connect hyaluronic acid chains to form a net.

Through optimisation of cross-linking reaction conditions in which a chemical reaction between the cross-linking agent and HA occurs, the use of the cross-linking agent is minimised, thereby maximising the efficiency of the cross-linking reaction.

Please note that on occasion product package design can change, we will always strive to show the present design where possible

*The majority of our products are designed for professional use by doctors and specialists, by purchasing said product(s) you agree to supply on request formal proof of medical/professional training. Said product(s) are not intended for personal or home use.

Please note this product has contraindications for use. It is recommended that all Healthcare professionals familiarise themselves with these contraindications and precautions by reading the instructions provided.